Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
11/2010
11/25/2010US20100298385 Protein kinase inhibitors useful for treatment of cancers
11/25/2010US20100298378 Aryl-substituted polycyclic amines, method for the production thereof, and use thereof as a medicament
11/25/2010US20100298346 Nitrogenous heterocyclic compounds with insecticidal activity, and the preparation and use thereof
11/25/2010US20100298340 Thiazol-Guanidine Derivatives Useful As A (Beta)-Related Pathologies
11/25/2010US20100298323 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
11/25/2010US20100298316 Benzothiazoles Having Histamine H3 Receptor Activity
11/25/2010US20100298303 Cgrp receptor antagonists
11/25/2010US20100298297 Tetrahydropyridothienopyrimidine Compounds and Methods of Use Thereof
11/25/2010US20100298295 2-biphenylamino-4-aminopyrimidine derivatives as kinase inhibitors
11/25/2010US20100298291 Fused bicyclic-substituted amines as histamine-3 receptor ligands
11/25/2010US20100298286 Organic Compounds
11/25/2010US20100298284 Benzamides and related inhibitors of factor xa
11/25/2010US20100298278 Inhibitors of beta-secretase for the treatment of alzheimer's disease
11/25/2010US20100297252 Nanoparticulate meloxicam formulations
11/25/2010US20100297097 Compounds
11/25/2010US20100297035 Thiazole Amides, Imidazole Amides and Related Analogues
11/25/2010CA2763099A1 Benzoxazepines based p13k/mt0r inhibitors against proliferative diseases
11/25/2010CA2762427A1 Nitrile derivatives and their pharmaceutical use and compositions
11/25/2010CA2753560A1 Inhibitors of phosphatidylinositol 3-kinase
11/24/2010EP2253625A1 Pyridazinones, the preparation and the use thereof
11/24/2010EP2253620A1 Substituted 3-cyanoquinolines as protein tyrosine kinases inhibitors
11/24/2010EP2253617A1 Halogenated compounds as pesticides
11/24/2010EP2253614A1 Inhibitors of IAP
11/24/2010EP2253327A1 Pharmaceutical composition containing a compound having angiotensin II antagonistic activity in combination with another compound
11/24/2010EP2252606A1 Pyrimidylmethyl sulfonamide compounds
11/24/2010EP2252604A1 Thiazole derivative and use thereof as vap-1 inhibitor
11/24/2010EP2252600A1 Substituted triazinylmethyl sulfonamides
11/24/2010EP2252597A2 Novel compounds, use and preparation thereof
11/24/2010EP2252594A2 5-fluoro pyrimidine derivatives as fungicides
11/24/2010EP2252590A1 Substituted sulfonic acid amide compounds
11/24/2010EP1899330B1 Substituted glycinamides having an antithrombotic and factor xa-inhibiting effect
11/24/2010EP1539739B1 Piperidinyl compounds that selectively bind integrins
11/24/2010EP1501829B1 Thiadiazoles or oxadiazoles and their use as inhibitors of jak protein kinase
11/24/2010EP1497287B1 Quinoline derivatives in combination with 5-FU or CPT-11 for use in the treatment of cancer
11/24/2010EP1497285B1 Benzoxazinone-derived compounds, their preparation und use as medicaments
11/24/2010EP1370260B1 Azoles as malonyl-coa decarboxylase inhibitors useful as metabolic modulators
11/24/2010EP1364946B1 Isoxazoline derivative and herbicide comprising the same as active ingredient
11/24/2010CN101896483A Glucokinase activators and pharmaceutical compositions containing the same as an active ingredient
11/24/2010CN101896469A Substituted hydantoins as MEK kinase inhibitors
11/24/2010CN101891738A Dasatinib polymorph and preparation method and medical composite thereof
11/24/2010CN101891737A Method for ammonolyzing and synthesizing meloxicam under catalysis of Lewis acid
11/24/2010CN101891736A 1,3,4-thiadiazole (oxadiazole) derivatives based on benzoisoselenothiazolidone structure, and preparation and application thereof
11/24/2010CN101891708A Diacylhydrazine compounds containing 4-methyl-1,2,3-thiadiazole groups, preparation method and application thereof
11/24/2010CN101891706A 3,4-dihydrobenzo[f][1,4]thiazepine compound or salts of same and medical use of same
11/24/2010CN101891680A Modulators of atp-binding cassette transporters
11/24/2010CN101891673A Organic material and application thereof in organic electroluminescence devices
11/24/2010CN101175722B Azetidine derivatives as ccr-3 receptor antagonists
11/24/2010CN101045715B Heterocycle inhibitor for glycogen synthase kinase gsk-3
11/23/2010US7838687 3-Methyl-2-{[3-(4-vinyl-benzyl)-3H-benzothiazol-2-ylidene]-hydrazono}-2,3-dihydro-benzothiazole-6-sulfonic acid; bioelectrocatalytic oxygen reduction to water; electrochromic devices; biofuel cells; biosensors; chromogen substrate/assays for enzymatic activity; nonleachable, solids; solvent resistance
11/23/2010US7838680 preparing triazole derivatives by reacting 4-Methyl-1,3-oxazole-5-carboxylic acid with 4-methyl-3 -thiosemicarbazide,followed by a treatment with an inorganic base and n-propane phosphonic cyclic anhydride, and pH adjustement with an inorganic acid
11/23/2010US7838671 Improved adhesion between various substrates, in particular between organic resins and inorganic materials, or metal materials. silane coupling agents; contains tertiary amine groups and carbonyl groups
11/23/2010US7838543 MCH receptor antagonists
11/23/2010US7838535 Compounds having β2 adrenergic receptor agonist and muscarinic receptor antagonist activity
11/23/2010US7838525 modulators of glucose metabolism, GPCR, RUP3; metabolic disorders and complications thereof such as diabetes and obesity; 4-[5-Cyano-6-(6-methylsulfanyl-pyridin-3-ylamino)-pyrimidin-4-yloxy]-piperidine-1-carboxylic acid tert-butyl ester
11/23/2010US7838523 [5-(Pyridin-2-ylamino)-6-oxo-1,6-dihydro-pyridin-3-yl]-(3-amido)-benzene derivatives; anticarcinogenic, antiproliferative, antiallergen, and antiinflammatory agents; lymphoma, leukemia, autoimmune diseases; Bruton's tyrosine kinase inhibitors
11/23/2010US7838518 1-(4-methoxynaphthalene-1-sulfonyl)-2,3-dihydro-1H-indole-3-carboxylic acid [2-(1-methyl-pyrrolidin-2-yl)-ethyl]amide; selective affinity for 5-HT6 receptor; psychosis, schizophrenia, depression, neurological disorders, cognitive enhancement, Parkinson's disease, ALS, Alzheimer's, Huntington's disease
11/23/2010US7837981 Methods for imaging soluble A-beta
11/23/2010CA2496295C Novels pyrazole compounds as transforming growth factor (tgf) inhibitors
11/23/2010CA2487489C Mitotic kinesin inhibitors
11/23/2010CA2459380C Reverse hydroxamic acid derivatives
11/18/2010WO2010132601A1 Antiviral compounds
11/18/2010WO2010132599A1 Compounds with two fused bicyclic heteroaryl moieties as modulators of leukotriene a4 hydrolase
11/18/2010WO2010131669A1 3-(4-aminophenyl)-2-furancarboxylic acid derivative and pharmaceutically acceptable salt thereof
11/18/2010WO2010131191A1 Thiazolidin-4-one and [1,3]-thiazinan-4-one compounds as orexin receptor antagonists
11/18/2010WO2010131147A1 Cyclobutenedione derivatives
11/18/2010WO2010131146A1 Cyclobutenedione derivatives
11/18/2010WO2010130945A1 7-aza-spiro[3.5]nonane-7-carboxylate derivatives, preparation thereof, and therapeutic use thereof
11/18/2010WO2010130944A1 Cyclopenta[c]pyrrole-2-carboxylate derivatives, preparation thereof, and therapeutic use thereof
11/18/2010WO2010130794A1 5-pyridin-3-yl-1,3-dihydro-indol-2-on derivatives and their use as modulators of aldosterone synthase and/or cyp11b1
11/18/2010WO2010130034A1 Inhibitors of human immunodeficiency virus replication
11/18/2010WO2010111626A3 Poly (adp-ribose) polymerase (parp) inhibitors
11/18/2010WO2010062715A3 Polymorphs of dasatinib and process for preparation thereof
11/18/2010WO2010059611A3 Inhibitors of diacylglycerol acyltransferase
11/18/2010WO2010034838A3 Antiproliferative compounds
11/18/2010WO2010033543A3 Substituted benzamides as cannabinoid receptor ligands
11/18/2010WO2009149858A8 Novel heteroaromatic amides and thioamides as pesticides
11/18/2010WO2009132785A8 Thiazol-4-carboxylic acid esters and thioesters as plant protection agents
11/18/2010US20100292487 Chemical process for the preparation of benzoxazole derivatives used as pesticides
11/18/2010US20100292284 Talarazole metabolites
11/18/2010US20100292275 Fungicidal heterocyclic compounds
11/18/2010US20100292274 Haloalkyl heteroaryl benzamide compounds
11/18/2010US20100292253 Pesticidal compositions
11/18/2010US20100292240 Sulfonamide compounds
11/18/2010US20100292227 Inhibitors of human immunodeficiency virus replication
11/18/2010US20100292219 Tertiary amine substituted peptides useful as inhibitors of hcv replication
11/18/2010US20100292208 Compounds with two fused bicyclic heteroaryl moieties as modulators of leukotriene a4 hydrolase
11/18/2010US20100292206 Heterocyclic compound
11/18/2010US20100292190 Novel tubulin polymerisation inhibitors
11/18/2010US20100292187 Methods for treating hepatitis c
11/18/2010US20100292143 Pyrrole-2-carboxamide derivatives as glucokinase activators, their process and pharmaceutical application
11/18/2010CA2762036A1 Inhibitors of human immunodeficiency virus replication
11/18/2010CA2761881A1 Compounds with two fused bicyclic heteroaryl moieties as modulators of leukotriene a4 hydrolase
11/18/2010CA2761858A1 5-pyridin-3-yl-1,3-dihydro-indol-2-on derivatives and their use as modulators of aldosterone synthase and/or cyp11b1
11/18/2010CA2761663A1 7-aza-spiro[3.5]nonane-7-carboxylate derivatives, preparation thereof, and therapeutic use thereof
11/18/2010CA2761660A1 Cyclopenta[c]pyrrole-2-carboxylate derivatives, preparation thereof, and therapeutic use thereof
11/18/2010CA2761258A1 Antiviral compounds
11/18/2010CA2758675A1 Novel oxazolidinone derivatives
11/18/2010CA2758202A1 Thiazolidin-4-one and [1,3]-thiazinan-4-one compounds as orexin receptor antagonists
11/17/2010EP2251336A1 Hydrazide compounds as intermediates of pesticides
11/17/2010EP2251327A2 Heterocyclic inhibitors of MEK and methods of use thereof
1 ... 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 ... 628